CAR-T CELL DYNAMICS ARE ASSOCIATED WITH CLINICAL OUTCOME IN PATIENTS TREATED WITH ANTI-CD19 CAR-T CELL THERAPY FOR RELAPSED/REFRACTORY B-CELL MALIGNANCIES: A REAL-LIFE COHORT STUDY

被引：0
|
作者：
Noviello, Maddalena [1 ]
De Felice, Francesco [1 ]
Bergonzi, Gregorio Maria [2 ]
Valtolina, Veronica [1 ]
Angelillo, Piera [1 ]
Greco, Raffaella [1 ]
Xue, Elisabetta [1 ]
Campodonico, Edoardo [1 ]
Lupo-Stanghellini, Maria Teresa [1 ]
Somai, Francesca [1 ,2 ]
Falcone, Laura [1 ]
Beretta, Valeria [1 ]
Tassi, Elena [1 ]
Peccatori, Jacopo [1 ]
Casucci, Monica [1 ]
Carrabba, Matteo [1 ]
Ciceri, Fabio [1 ,2 ]
Bonini, Chiara [1 ,2 ]
机构：
[1] IRCCS Osped San Raffaele, Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P081
引用
收藏
页码：206 / 207
页数：2
相关论文
共 50 条
  • [1] Anti-CD22 CAR-T Cell Therapy as a Salvage Treatment in B Cell Malignancies Refractory or Relapsed After Anti-CD19 CAR-T therapy
    Zhu, Haibo
    Deng, Haobin
    Mu, Juan
    Lyu, Cuicui
    Jiang, Yanyu
    Deng, Qi
    [J]. ONCOTARGETS AND THERAPY, 2021, 14 : 4023 - 4037
  • [2] Efficacy of anti-CD19 CAR-T cell therapy in 10 refractory recurrent B cell malignancies
    包芳
    [J]. China Medical Abstracts (Internal Medicine), 2018, 35 (03) : 186 - 187
  • [3] Subsequent Secondary CAR-T Cell Therapy Was Superior to Chemotherapy in Patients with Refractory/Relapsed BCell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy
    Yang, Fan
    Liu, Rui
    Xu, Teng
    Zheng, Peihao
    Feng, Shaomei
    Guo, Yuelu
    Ma, Lixia
    Shi, Hui
    Deng, Biping
    Ke, Xiaoyan
    Wu, Tong
    Hu, Kai
    [J]. BLOOD, 2022, 140 : 10384 - 10385
  • [4] Anti-CD19/CD22 Dual CAR-T Therapy for Refractory and Relapsed B-Cell Acute Lymphoblastic Leukemia
    Yang, Junfang
    Jiang, Pengfei
    Zhang, Xian
    Zhu, Xiaobin
    Dong, Qi
    He, Jiaping
    Lin, Nanjing
    Wang, Zhenguang
    Cai, Songbai
    Ye, Xun
    Su, Yunchao
    Li, Wenqian
    Li, Jingjing
    Yu, Ziyao
    He, Jiujiang
    Xu, Li
    Song, Dan
    Cao, Wei
    Lu, Peihua
    [J]. BLOOD, 2019, 134
  • [5] CAR-T Engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma
    Su, Lihe
    Wu, Lan
    Lobb, Roy R.
    Rennert, Paul D.
    Ambrose, Christine
    [J]. ONCOIMMUNOLOGY, 2022, 11 (01):
  • [6] CAR-T ENGAGER PROTEINS OPTIMIZE ANTI-CD19 CAR-T CELL THERAPIES FOR LYMPHOMA
    Rennert, Paul
    Su, Lihe
    Wu, Lan
    Lobb, Roy
    Ambrose, Christine
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A187 - A187
  • [7] Management of relapsed or refractory large B-cell lymphoma in patients ineligible for CAR-T cell therapy
    Perrone, Salvatore
    Lopedote, Paolo
    Levis, Mario
    Di Rocco, Alice
    Smith, Stephen Douglas
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (03) : 215 - 232
  • [8] Humanized Anti-CD19 CAR-T Cell Therapy and Sequential Allogeneic Hematopoietic Stem Cell Transplantation Achieved Long-Term Survival in Refractory and Relapsed B Lymphocytic Leukemia: A Retrospective Study of CAR-T Cell Therapy
    Chen, Wei
    Ma, Yuhan
    Shen, Ziyuan
    Chen, Huimin
    Ma, Ruixue
    Yan, Dongmei
    Shi, Ming
    Wang, Xiangmin
    Song, Xuguang
    Sun, Cai
    Cao, Jiang
    Cheng, Hai
    Zhu, Feng
    Sun, Haiying
    Li, Depeng
    Li, Zhenyu
    Zheng, Junnian
    Xu, Kailin
    Sang, Wei
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [9] Allogeneic and Autologous Anti-CD7 CAR-T Cell Therapies in Relapsed or Refractory T Cell Malignancies
    Zhang, Yinqiang
    Li, Chenggong
    Jiang, Huiwen
    Luo, Wenjing
    Du, Mengyi
    Zhou, Fen
    Tang, Lu
    Wu, Jianghua
    Wei, Qiuzhe
    Lu, Cong
    Kou, Haiming
    Wu, Di
    Alex, Chang H.
    Mei, Heng
    Hu, Yu
    [J]. BLOOD, 2022, 140 : 4592 - 4594
  • [10] Overcoming resistance to anti-CD19 CAR T-cell therapy in B-cell malignancies
    Yang, Xingcheng
    Wei, Jia
    Zhou, Jianfeng
    [J]. HEMATOLOGICAL ONCOLOGY, 2022, 40 (05) : 821 - 834
12345